Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shailendra Kumar Verma

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|December 27, 2016
Plague Vaccine Development: Current Research and Future TrendsShailendra Kumar Verma, Urmil Tuteja
Vaccines|June 28, 2023
Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent VaccinationDivyasha Saxena, Lalit Batra, Shailendra Kumar Verma
Pathogens (Basel, Switzerland)|June 28, 2023
Broad-Spectrum Antivirals against Multiple Human and Animal Coronaviruses InfectionDivyasha Saxena, Lalit Batra, Shailendra Kumar Verma
World Journal of Microbiology & Biotechnology|July 19, 2012
Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB/c miceShailendra Kumar Verma, Shikha Jain, Subodh Kumar
Vaccines|January 21, 2023
Determination of Conformational and Functional Stability of Potential Plague Vaccine Candidate in FormulationKrubha Athirathinam, Selvasudha Nandakumar, Shailendra Kumar Verma, et al.
Frontiers in Immunology|June 30, 2020
Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and YersiniosisAnkit Gupta, Bineet Narayan, Subodh Kumar, et al.
Bioengineering (Basel, Switzerland)|January 21, 2023
Role of G-Proteins and GPCRs in Cardiovascular PathologiesGeetika Kaur, Shailendra Kumar Verma, Deepak Singh, et al.
Experimental & Molecular Medicine|July 31, 2024
A neutrophil elastase-generated mature form of IL-33 is a potent regulator of endothelial cell activation and proliferative retinopathyShivantika Bisen, Shailendra Kumar Verma, Chandra Sekhar Mukhopadhyay, et al.
Microbes and Infection|July 12, 2023
Protective antigen of Bacillus anthracis in combination with TLR4 or TLR5 agonist confers superior protection against lethal challenge in mouse modelBineet Narayan, Shailendra Kumar Verma, Sandeep Singh, et al.
The International Journal of Biochemistry & Cell Biology|April 25, 2012
Non-muscle myosin IIA transports a Golgi glycosyltransferase to the endoplasmic reticulum by binding to its cytoplasmic tailArmen Petrosyan, Mohamed F Ali, Shailendra Kumar Verma, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|December 27, 2016
Plague Vaccine Development: Current Research and Future TrendsShailendra Kumar Verma, Urmil Tuteja
Vaccines|June 28, 2023
Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent VaccinationDivyasha Saxena, Lalit Batra, Shailendra Kumar Verma
Pathogens (Basel, Switzerland)|June 28, 2023
Broad-Spectrum Antivirals against Multiple Human and Animal Coronaviruses InfectionDivyasha Saxena, Lalit Batra, Shailendra Kumar Verma
World Journal of Microbiology & Biotechnology|July 19, 2012
Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB/c miceShailendra Kumar Verma, Shikha Jain, Subodh Kumar
Vaccines|January 21, 2023
Determination of Conformational and Functional Stability of Potential Plague Vaccine Candidate in FormulationKrubha Athirathinam, Selvasudha Nandakumar, Shailendra Kumar Verma, et al.
Frontiers in Immunology|June 30, 2020
Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and YersiniosisAnkit Gupta, Bineet Narayan, Subodh Kumar, et al.
Bioengineering (Basel, Switzerland)|January 21, 2023
Role of G-Proteins and GPCRs in Cardiovascular PathologiesGeetika Kaur, Shailendra Kumar Verma, Deepak Singh, et al.
Experimental & Molecular Medicine|July 31, 2024
A neutrophil elastase-generated mature form of IL-33 is a potent regulator of endothelial cell activation and proliferative retinopathyShivantika Bisen, Shailendra Kumar Verma, Chandra Sekhar Mukhopadhyay, et al.
Microbes and Infection|July 12, 2023
Protective antigen of Bacillus anthracis in combination with TLR4 or TLR5 agonist confers superior protection against lethal challenge in mouse modelBineet Narayan, Shailendra Kumar Verma, Sandeep Singh, et al.
The International Journal of Biochemistry & Cell Biology|April 25, 2012
Non-muscle myosin IIA transports a Golgi glycosyltransferase to the endoplasmic reticulum by binding to its cytoplasmic tailArmen Petrosyan, Mohamed F Ali, Shailendra Kumar Verma, et al.
Pageof 3